H. pylori eradication and metachronous gastric cancer risk

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1650, 2008-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

H. pylori eradication reduces the risk of NSAID-induced peptic ulcers

Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Positively Charged Gelatin Microspheres as Gastric Mucoadhesive Drug Delivery System for Eradication of H. pylori

By Wang Jian Tauchi Yoshihiko Deguchi Yoshiharu Morimoto Kazuhiro Tabata Yasuhiko Ikada Yashito

Drug Delivery, Vol. 7, Iss. 4, 2000-10 ,pp. : 237-243

Informa Healthcare

Access to resources Recommend Favorite

Enhancement in the Protective Qualities of Gastric Mucus with Combination Therapy of Ebrotidine and Amoxicillin for H. pylori Eradication - effect of ebrotidine and ranitidine

By Slomiany B.L. Piotrowski J. Slomiany Konturek W. Domschke W.W.

General Pharmacology, Vol. 31, Iss. 2, 1998-08 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

H. pylori eradication cost effective for peptic ulcer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 310, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

H. pylori eradication improves QOL in dyspepsia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 353, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite